This could be due to the timing of tissue analysis, at 1 month following tumor induction, or that our comparison to NPp53 prostates, where p53 deletion promotes repetitive element expression and dsRNA formation, affected our ability to detect elevated dsRNA signaling. This evidence concerns the gene TP53 and neoplasm.